Probabilistic Analysis and Computationally Expensive Models: Necessary and Required?
- 1 July 2006
- journal article
- Published by Elsevier in Value in Health
- Vol. 9 (4) , 244-252
- https://doi.org/10.1111/j.1524-4733.2006.00107.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence?Value in Health, 2005
- Probabilistic sensitivity analysis for NICE technology assessment: not an optional extraHealth Economics, 2005
- Evidence‐Based Medicine, Heterogeneity of Treatment Effects, and the Trouble with AveragesThe Milbank Quarterly, 2004
- Expected Value of Sample Information Calculations in Medical Decision ModelingMedical Decision Making, 2004
- Gaussian Process Modeling in Conjunction with Individual Patient Simulation Modeling: A Case Study Describing the Calculation of Cost-Effectiveness Ratios for the Treatment of Established OsteoporosisMedical Decision Making, 2004
- Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux DiseaseMedical Decision Making, 2002
- Health Economic Guidelines—Similarities, Differences and Some ImplicationsValue in Health, 2001
- BAYESIAN VALUE-OF-INFORMATION ANALYSISInternational Journal of Technology Assessment in Health Care, 2001
- The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologiesJournal of Health Economics, 1999
- An economic approach to clinical trial design and research priority-settingHealth Economics, 1996